KNBIF (Kane Biotech) Net Margin %: -1,680.65% (As of Mar. 2026)


What is Kane Biotech Net Margin %?

Kane Biotech KNBIF +5.19% Net Margin % is -1,680.65% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 947 Biotechnology companies, Kane Biotech ranks worse than 88.07% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Kane Biotech's Net Income for the three months ended in Mar. 2026 was $-0.52 Mil. Kane Biotech's Revenue for the three months ended in Mar. 2026 was $0.03 Mil. Therefore, Kane Biotech's net margin for the quarter that ended in Mar. 2026 was -1,680.65%.

The historical rank and industry rank for Kane Biotech's Net Margin % or its related term are showing as below:

KNBIF' s Net Margin % Range Over the Past 10 Years
Min: -3824.14   Med: -640.11   Max: 293.03
Current: -3824.14

KNBIF's Net Margin % is ranked worse than
88.07% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs KNBIF: -3824.14

Kane Biotech  (OTCPK:KNBIF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Kane Biotech Net Margin % Related Terms

Kane Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Net Margin % Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -286.46 -2,468.10 -3,380.18 292.95 -636.13

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -294.44 -1,275.00 -7,316.67 2,646.67 -1,680.65

KNBIF vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Kane Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Kane Biotech's Net Margin % falls into.


Kane Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Kane Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.972/0.31
=-636.13 %

Kane Biotech's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.521/0.031
=-1,680.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1,680.65% mean?
Kane Biotech (KNBIF) has a Net Margin % of -1,680.65% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #834 out of 947 companies in the Biotechnology industry, placing it in the top 88.1%.
Is Kane Biotech's Net Margin % too high?
Kane Biotech's current Net Margin % is -1,680.65%. Based on the distribution chart, Kane Biotech ranks #834 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Kane Biotech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #834 out of 947 companies for Net Margin %. This places Kane Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Kane Biotech and its competitors. Kane Biotech's current Net Margin % is -1,680.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Net Margin % of -1,680.65%. The current Net Margin % is -1,680.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Net Margin % is -1,680.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.